SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bioventus Inc. of Class Action Lawsuit

New York, Jan. 21, 2023 (GLOBE NEWSWIRE)

Pomerantz LLP announces that a class action lawsuit has been filed against Bioventus Inc. (“Bioventus” or the “Company”) (NASDAQ: BVS) and certain officers and directors. The class action, filed in the United States District Court for the Middle District of North Carolina, and docketed under 23-cv-00032, alleges that defendants made materially false and misleading statements regarding the Company’s business, operational, and compliance policies.

Impact on Individuals:

As an individual investor who has suffered losses on their investment in Bioventus Inc., this class action lawsuit serves as a reminder of the importance of conducting thorough due diligence before making investment decisions. It highlights the risks associated with investing in publicly traded companies and the potential consequences of misleading information provided by company officers and directors.

Impact on the World:

The filing of this class action lawsuit against Bioventus Inc. raises concerns about corporate governance and transparency in the business world. It emphasizes the need for regulatory oversight and investor protection measures to prevent companies from engaging in fraudulent activities that can harm shareholders and the overall market integrity.

In conclusion, the class action lawsuit against Bioventus Inc. serves as a wake-up call for both individual investors and the corporate world. It underscores the importance of accountability, transparency, and ethical business practices in maintaining the trust of shareholders and upholding the integrity of the global financial system.